Viatris, Biocon 
Dealstreet

Khaitan & Co, JSA, TT&A, Baker & McKenzie act on Viatris Inc's ₹3,680 crore exit from Biocon

Viatris Inc. sold off its entire stake of upto 5.64% in Biocon.

Bar & Bench

Viatris Inc. has divested its entire stake of upto 5.64% in Biocon Limited on the screen-based trading platform of the BSE Limited and the National Stock Exchange of India for ₹3,680 crore, making a complete exit.

Khaitan & Co advised Viatris Inc. on this transaction.

The transaction team consisted of Rabindra Jhunjhunwala (Partner), Chirayu Chandani (Partner), Abhishek Dadoo (Partner), Aman Anand (Counsel), Gaurang Mansinghka (Senior Associate), Hrithik Khurana (Senior Associate) and Nitya Saxena (Senior Associate).

Rabindra Jhunjhunwala, Chirayu Chandani, Abhishek Dadoo

JSA Advocates & Solicitors has advised Jefferies India, one of the brokers on this stake sale.

The transaction was led by Arka Mookerjee (Partner), with support from Pracheta Bhattacharya (Partner) and Arjun Rastogi (Principal Associate).

Arka Mookerjee, Pracheta Bhattacharya

TT&A advised Citigroup Global Markets India, the other broker acting on this stake sale.

The transaction team consisted of Abhinav Kumar (Partner), Shubham Sancheti (Managing Associate) and Abhishek Iyer (Senior Associate).

Abhinav Kumar

Baker & McKenzie served as the international legal counsel to Citigroup Global Markets India.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Karnataka High Court calls for integrated database of criminal cases

Slaughter and May, Eversheds Sutherland, Khaitan & Co act on Brahma AI $150 million fundraise

Saurav Ganguly moves Delhi High Court against movie Doosra, claims rights over Lord's shirtless celebration

Tryst with the Constitution: On the immunity of election commissioners

Nothing wrong in call for regime change: Neha Bora to Delhi High Court in SEM notice case

SCROLL FOR NEXT